SEK74.00
0.27% today
Stockholm, Aug 26, 05:24 pm CET
ISIN
SE0009806284
Symbol
PAX

Paxman Stock price

SEK73.80
-9.00 10.87% 1M
+9.20 14.24% 6M
+8.20 12.50% YTD
+23.40 46.43% 1Y
+22.80 44.71% 3Y
+36.40 97.33% 5Y
+62.10 530.77% 10Y
+62.10 530.77% 20Y
Stockholm, Closing price Mon, Aug 25 2025
-1.00 1.34%
ISIN
SE0009806284
Symbol
PAX

Key metrics

Basic
Market capitalization
SEK1.7b
Enterprise Value
SEK1.6b
Net debt
positive
Cash
SEK152.7m
Shares outstanding
20.9m
Valuation (TTM | estimate)
P/E
64.7 | 99.4
P/S
6.7 | 4.9
EV/Sales
6.1 | 4.5
EV/FCF
105.1
P/B
6.3
Financial Health
Equity Ratio
72.2%
Return on Equity
24.5%
ROCE
11.5%
ROIC
22.1%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
SEK261.5m | SEK352.5m
EBITDA
SEK48.4m | SEK104.0m
EBIT
SEK32.3m | SEK82.8m
Net Income
SEK21.6m | SEK15.5m
Free Cash Flow
SEK15.2m
Growth (TTM | estimate)
Revenue
15.5% | 39.3%
EBITDA
20.1% | 109.2%
EBIT
49.0% | 147.2%
Net Income
-10.0% | -61.4%
Free Cash Flow
-22.6%
Margin (TTM | estimate)
Gross
68.6%
EBITDA
18.5% | 29.5%
EBIT
12.4%
Net
8.3% | 4.4%
Free Cash Flow
5.8%
More
EPS
SEK1.1
FCF per Share
SEK0.7
Short interest
-
Employees
105
Rev per Employee
SEK2.4m
Show more

Is Paxman a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

Financial data from Paxman

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
262 262
16% 16%
100%
- Direct Costs 82 82
19% 19%
31%
179 179
14% 14%
69%
- Selling and Administrative Expenses 71 71
17% 17%
27%
- Research and Development Expense - -
-
-
48 48
20% 20%
18%
- Depreciation and Amortization 16 16
14% 14%
6%
EBIT (Operating Income) EBIT 32 32
49% 49%
12%
Net Profit 22 22
10% 10%
8%

In millions SEK.

Don't miss a Thing! We will send you all news about Paxman directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Paxman AB engages in the research and development of scalp cooling system. It focuses on its product, PAXMAN Scalp Cooling System, which is used to minimize hair loss in connection with chemotherapy treatment. The company was founded by Glenn Ann Paxman in 1996 and is headquartered in Karlshamn, Sweden.

Head office Sweden
CEO Richard Paxman
Employees 105
Founded 2016
Website www.paxman.se

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today